Principal Financial Group Inc. boosted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 0.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 267,885 shares of the biotechnology company’s stock after purchasing an additional 1,101 shares during the quarter. Principal Financial Group Inc. owned about 0.36% of Axon Enterprise worth $60,234,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new position in Axon Enterprise during the first quarter worth $373,000. Archer Investment Corp bought a new position in Axon Enterprise during the first quarter worth $84,000. Spire Wealth Management acquired a new stake in shares of Axon Enterprise during the first quarter worth $31,000. Tower Research Capital LLC TRC lifted its holdings in shares of Axon Enterprise by 11.8% during the first quarter. Tower Research Capital LLC TRC now owns 2,042 shares of the biotechnology company’s stock worth $460,000 after buying an additional 215 shares in the last quarter. Finally, Nicolet Advisory Services LLC acquired a new stake in shares of Axon Enterprise during the first quarter worth $307,000. 76.47% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of research firms have recently weighed in on AXON. JPMorgan Chase & Co. raised Axon Enterprise from a “neutral” rating to an “overweight” rating and set a $236.00 target price for the company in a report on Thursday, May 11th. Robert W. Baird lifted their target price on Axon Enterprise from $237.00 to $240.00 in a report on Thursday, May 11th. Northland Securities lifted their target price on Axon Enterprise from $227.00 to $235.00 and gave the stock an “outperform” rating in a report on Friday, August 11th. TheStreet downgraded Axon Enterprise from a “b-” rating to a “c+” rating in a report on Friday, May 26th. Finally, Credit Suisse Group lifted their target price on Axon Enterprise from $300.00 to $309.00 in a report on Wednesday, May 10th. Two analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $237.91.
Get Our Latest Stock Report on Axon Enterprise
Axon Enterprise Stock Down 2.7 %
Shares of NASDAQ AXON opened at $195.39 on Friday. The company has a current ratio of 3.38, a quick ratio of 2.98 and a debt-to-equity ratio of 0.47. The company has a market cap of $14.61 billion, a price-to-earnings ratio of 145.81 and a beta of 0.88. Axon Enterprise, Inc. has a 12 month low of $109.31 and a 12 month high of $229.95. The stock has a 50-day moving average price of $192.23 and a two-hundred day moving average price of $203.32.
Insiders Place Their Bets
In other Axon Enterprise news, Director Hadi Partovi bought 10,000 shares of the stock in a transaction on Thursday, May 25th. The stock was purchased at an average price of $190.75 per share, with a total value of $1,907,500.00. Following the completion of the purchase, the director now owns 388,817 shares in the company, valued at $74,166,842.75. The purchase was disclosed in a filing with the SEC, which is accessible through this link. In other news, President Joshua Isner sold 26,883 shares of the business’s stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $193.10, for a total transaction of $5,191,107.30. Following the sale, the president now directly owns 290,965 shares in the company, valued at $56,185,341.50. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Hadi Partovi purchased 10,000 shares of Axon Enterprise stock in a transaction dated Thursday, May 25th. The shares were purchased at an average price of $190.75 per share, for a total transaction of $1,907,500.00. Following the completion of the acquisition, the director now owns 388,817 shares of the company’s stock, valued at approximately $74,166,842.75. The disclosure for this purchase can be found here. Over the last 90 days, insiders sold 54,458 shares of company stock valued at $10,534,340. 6.10% of the stock is currently owned by corporate insiders.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Axon Enterprise wasn’t on the list.
While Axon Enterprise currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Click the link below and we’ll send you MarketBeat’s list of the 10 best stocks to own in 2023 and why they should be in your portfolio.
